
Agenus/LinkedIn
Feb 26, 2025, 09:26
New translational insights on immune activation in refractory gastric cancer presented at AACRIO25 – Agenus
Agenus shared a post on LinkedIn:
“Yesterday at AACRIO25, we presented new translational insights demonstrating the strong immune activation driven by BOT/BAL in combination with chemotherapy and MiNK Therapeutics’ allo-iNKTs in refractory gastric cancer.
Read more about the data.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 28, 2025, 15:23
Mar 28, 2025, 14:56
Mar 28, 2025, 14:46
Mar 28, 2025, 14:24